BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 18701488)

  • 1. Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation.
    Kotliarova S; Pastorino S; Kovell LC; Kotliarov Y; Song H; Zhang W; Bailey R; Maric D; Zenklusen JC; Lee J; Fine HA
    Cancer Res; 2008 Aug; 68(16):6643-51. PubMed ID: 18701488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells.
    Marchand B; Arsenault D; Raymond-Fleury A; Boisvert FM; Boucher MJ
    J Biol Chem; 2015 Feb; 290(9):5592-605. PubMed ID: 25561726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer.
    Liao X; Zhang L; Thrasher JB; Du J; Li B
    Mol Cancer Ther; 2003 Nov; 2(11):1215-22. PubMed ID: 14617795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase 3 protein kinase activity is frequently elevated in human non-small cell lung carcinoma and supports tumour cell proliferation.
    Vincent EE; Elder DJ; O'Flaherty L; Pardo OE; Dzien P; Phillips L; Morgan C; Pawade J; May MT; Sohail M; Hetzel MR; Seckl MJ; Tavaré JM
    PLoS One; 2014; 9(12):e114725. PubMed ID: 25486534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
    Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
    Dokken BB; Sloniger JA; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
    Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
    Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
    Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
    Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial matrix chaperone and c-myc inhibition causes enhanced lethality in glioblastoma.
    Ishida CT; Shu C; Halatsch ME; Westhoff MA; Altieri DC; Karpel-Massler G; Siegelin MD
    Oncotarget; 2017 Jun; 8(23):37140-37153. PubMed ID: 28415755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis.
    Spokoini R; Kfir-Erenfeld S; Yefenof E; Sionov RV
    Mol Endocrinol; 2010 Jun; 24(6):1136-50. PubMed ID: 20371704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKT/SGK-sensitive phosphorylation of GSK3 in the regulation of L-selectin and perforin expression as well as activation induced cell death of T-lymphocytes.
    Bhavsar SK; Merches K; Bobbala D; Lang F
    Biochem Biophys Res Commun; 2012 Aug; 425(1):6-12. PubMed ID: 22814108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3β is involved in ligand-dependent activation of transcription and cellular localization of the glucocorticoid receptor.
    Rubio-Patiño C; Palmeri CM; Pérez-Perarnau A; Cosialls AM; Moncunill-Massaguer C; González-Gironès DM; Pons-Hernández L; López JM; Ventura F; Gil J; Pons G; Iglesias-Serret D
    Mol Endocrinol; 2012 Sep; 26(9):1508-20. PubMed ID: 22771494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function.
    Rottmann S; Wang Y; Nasoff M; Deveraux QL; Quon KC
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15195-200. PubMed ID: 16210249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
    J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth.
    Dudgeon C; Peng R; Wang P; Sebastiani A; Yu J; Zhang L
    Oncogene; 2012 Nov; 31(46):4848-58. PubMed ID: 22286758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells.
    Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Choi J
    PLoS One; 2013; 8(4):e60383. PubMed ID: 23565238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms.
    Marchand B; Tremblay I; Cagnol S; Boucher MJ
    Carcinogenesis; 2012 Mar; 33(3):529-37. PubMed ID: 22201186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax.
    Somervaille TC; Linch DC; Khwaja A
    Blood; 2001 Sep; 98(5):1374-81. PubMed ID: 11520785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption.
    Watcharasit P; Thiantanawat A; Satayavivad J
    J Appl Toxicol; 2008 May; 28(4):466-74. PubMed ID: 17849503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.